XMTR
Xometry Inc
$
48.570
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
49.715
Open
48.910
VWAP
48.16
Vol
706.62K
Mkt Cap
2.47B
Low
47.3484
Amount
34.03M
EV/EBITDA(TTM)
--
Total Shares
48.80M
EV
2.57B
EV/OCF(TTM)
1.93K
P/S(TTM)
4.03
Xometry, Inc. provides an artificial intelligence (AI)-powered marketplace, the Thomasnet.com industrial sourcing platform and a suite of cloud-based services. The Company provides manufacturers with the critical resources they need to grow their business and makes it easy for buyers to create locally resilient supply chains. It connects buyers with suppliers of manufacturing services. Xometry Instant Quoting Engine leverages millions of pieces of data to analyze complex parts in real-time, matches buyers with the right suppliers globally, and provides pricing and lead times. Its AI-enabled technology platform is powered by machine learning algorithms and datasets, resulting in a two-sided marketplace. It uses technology to enable product designers, engineers, buyers, and supply chain professionals to access the capacity of a global network of manufacturing facilities. Its suppliers’ capabilities include computer numerical control manufacturing, and sheet cutting, among others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
168.25M
+18.74%
0.102
+411.45%
175.79M
+18.34%
0.127
+112.05%
179.35M
+18.8%
0.114
+467.95%
Estimates Revision
The market is revising Upward the revenue expectations for Xometry, Inc. (XMTR) for FY2025, with the revenue forecasts being adjusted by 1.15% over the past three months. During the same period, the stock price has changed by 56.83%.
Revenue Estimates for FY2025
Revise Upward
+1.15%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+20.02%
In Past 3 Month
Stock Price
Go Up
+56.83%
In Past 3 Month
10 Analyst Rating
-0.27% Downside
Wall Street analysts forecast XMTR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XMTR is 48.44 USD with a low forecast of 40.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
4 Hold
0 Sell
Moderate Buy
-0.27% Downside
Current: 48.570
Low
40.00
Averages
48.44
High
55.00
-0.27% Downside
Current: 48.570
Low
40.00
Averages
48.44
High
55.00
Goldman Sachs
Neutral
maintain
$42 -> $49
2025-10-17
Reason
Goldman Sachs
Price Target
$42 -> $49
2025-10-17
maintain
Neutral
Reason
Goldman Sachs raised the firm's price target on Xometry to $49 from $42 and keeps a Neutral rating on the shares.
Goldman Sachs
Buy
to
Neutral
downgrade
$42 -> $49
2025-10-16
Reason
Goldman Sachs
Price Target
$42 -> $49
2025-10-16
downgrade
Buy
to
Neutral
Reason
Goldman Sachs downgraded Xometry to Neutral from Buy with a price target of $49, up from $42. The firm cites valuation for the downgrade with the shares up 124% in the past six months. Xometry now trades toward the high end of its multiple ranges since 2023, the analyst tells investors in a research note.
Cantor Fitzgerald
Underweight -> Neutral
upgrade
$21 -> $41
2025-08-06
Reason
Cantor Fitzgerald
Price Target
$21 -> $41
2025-08-06
upgrade
Underweight -> Neutral
Reason
Cantor Fitzgerald upgraded Xometry to Neutral from Underweight with a price target of $41, up from $21. Xometry reported better-than-expected June quarter results for revenue, adjusted EBITDA, margins, and non-GAAP EPS, the analyst tells investors in a research note. Investments in the platform have enabled Xometry to win larger enterprise customers and to become a strategic sourcing partner, and has eliminated refinancing risk with the recent restructuring of its convertible debt, the firm says.
Citizens JMP
Andrew Boone
Outperform
maintain
$45 -> $50
2025-08-06
Reason
Citizens JMP
Andrew Boone
Price Target
$45 -> $50
2025-08-06
maintain
Outperform
Reason
Citizens JMP analyst Andrew Boone raised the firm's price target on Xometry to $50 from $45 and keeps an Outperform rating on the shares. Xometry reported better-than-expected results as revenue and EBITDA came in above the high end of guidance, with all key performance indicators "healthy" as the company added 3.3K new Active Buyers, the analyst tells investors in a research note. With Xometry supporting its business through greater coverage of Instant Quoting and deeper integrations across manufacturers' software and processes, growth appears to have reset in the mid-20% range after teens growth in 2024, the firm says.
UBS
Neutral
maintain
$35 -> $40
2025-08-06
Reason
UBS
Price Target
$35 -> $40
2025-08-06
maintain
Neutral
Reason
UBS raised the firm's price target on Xometry to $40 from $35 and keeps a Neutral rating on the shares. Revenue, gross margin, and EBITDA all came in ahead of expectations in Q2 despite a still uncertain macro backdrop, the analyst tells investors in a research note. While Xometry embedded some growth moderation in the second half due to macro conservatism, July is said to be off to a strong start and growth momentum remains strong, UBS says.
Cantor Fitzgerald
Troy Jensen
Underweight -> Neutral
upgrade
2025-08-05
Reason
Cantor Fitzgerald
Troy Jensen
Price Target
2025-08-05
upgrade
Underweight -> Neutral
Reason
Cantor Fitzgerald analyst Troy Jensen upgraded Xometry to Neutral from Underweight.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Xometry Inc (XMTR.O) is 95.94, compared to its 5-year average forward P/E of -16.57. For a more detailed relative valuation and DCF analysis to assess Xometry Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-16.57
Current PE
95.94
Overvalued PE
69.52
Undervalued PE
-102.67
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
103.96
Current EV/EBITDA
104.97
Overvalued EV/EBITDA
554.52
Undervalued EV/EBITDA
-346.60
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
3.72
Current PS
48.69
Overvalued PS
7.57
Undervalued PS
-0.13
Financials
Annual
Quarterly
FY2025Q2
YoY :
+22.59%
162.55M
Total Revenue
FY2025Q2
YoY :
-37.83%
-9.52M
Operating Profit
FY2025Q2
YoY :
+92.91%
-26.44M
Net Income after Tax
FY2025Q2
YoY :
+85.71%
-0.52
EPS - Diluted
FY2025Q2
YoY :
-45.28%
-7.39M
Free Cash Flow
FY2025Q2
YoY :
+0.55%
40.10
Gross Profit Margin - %
FY2025Q2
YoY :
-63.67%
-3.39
FCF Margin - %
FY2025Q2
YoY :
+57.25%
-16.26
Net Margin - %
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 1679.43% over the last month.
Sold
0-3
Months
564.7K
USD
3
3-6
Months
332.4K
USD
2
6-9
Months
1.3M
USD
7
0-12
Months
1.3M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
11.4K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
2
47.4K
Volume
Months
0-12
2
44.1K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 1679.43% over the last month.
Sold
0-3
Months
564.7K
USD
3
3-6
Months
332.4K
USD
2
6-9
Months
1.3M
USD
7
0-12
Months
1.3M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
XMTR News & Events
Events Timeline
2025-10-23 (ET)
2025-10-23
09:13:05
Xometry Introduces Automated Quoting for Injection Molding Services in the U.S.
2025-10-09 (ET)
2025-10-09
09:16:25
Xometry unveils new Workcenter Mobile App
2025-08-05 (ET)
2025-08-05
11:12:20
Video: Palantir, Axon lead early movers after earnings
Sign Up For More Events
Sign Up For More Events
News
8.0
11-03WSJThe U.S. Economy's Resilience Against Pessimistic Tariff Forecasts
3.5
10-23NewsfilterXometry Launches Auto-Quote Feature for Injection Molding Services, Enhancing Its Digital Manufacturing Platform
5.0
10-09NewsfilterXometry Introduces Enhanced Workcenter Experience, Enabling Manufacturing Partners to Accept Jobs and Manage Tasks Remotely
Sign Up For More News
People Also Watch
EPC
Edgewell Personal Care Co
19.200
USD
-0.98%
QBTS
D-Wave Quantum Inc
33.090
USD
-10.71%
CENTA
Central Garden & Pet Co
28.090
USD
+1.01%
WKC
World Kinect Corp
26.100
USD
+0.97%
CODI
Compass Diversified Holdings
6.180
USD
-3.13%
IAS
Integral Ad Science Holding Corp
10.220
USD
+0.10%
ARHS
Arhaus Inc
9.860
USD
-1.60%
PEB
Pebblebrook Hotel Trust
10.540
USD
+0.76%
ATEC
Alphatec Holdings Inc
19.290
USD
+1.58%
DVAX
Dynavax Technologies Corp
10.190
USD
-0.68%
FAQ
What is Xometry Inc (XMTR) stock price today?
The current price of XMTR is 48.57 USD — it has decreased -0.25 % in the last trading day.
What is Xometry Inc (XMTR)'s business?
What is the price predicton of XMTR Stock?
What is Xometry Inc (XMTR)'s revenue for the last quarter?
What is Xometry Inc (XMTR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Xometry Inc (XMTR)'s fundamentals?
How many employees does Xometry Inc (XMTR). have?
